[1]
“Features of percutaneous therapy in non-ST-segment elevation myocardial infarction patients who were admitted to hospital at different times since the onset of symptoms”, UJC, vol. 26, no. 6, pp. 11–26, Feb. 2020, doi: 10.31928/1608-635X-2019.6.1126.